Observational Study to Evaluate the Safety of Levemir® in Diabetes

Observational, Safety Study in Subjects Using Levemir® (Insulin Detemir) for the Treatment of Insulin Dependent Type 1 or Type 2 Diabetes Mellitus

This observational study is conducted in North America. The aim of this observational study is to evaluate the incidence of adverse events while using Levemir® under normal clinical practice conditions.

Inclusion Criteria:

• Type 1 or 2 diabetes
• Including newly diagnosed not on insulin or insulin analogue treatment
• Selection at the discretion of the physician
• Adult patients with type 1 and 2 diabetes mellitus, and type 1 patients 6 years and older

Exclusion Criteria:

• Current treatment with Levemir®
• Previously enrolled in the study
• Hypersensitivity to Levemir®